Successful Collagen Crosslinking in a Patient With Keratoconus and Systemic Scleroderma.
| Autor: | Alghamdi A; Oculoplastic Division, King Khaled Eye Specialist Hospital, Riyadh, SAU., Alghamdi EA; College of Medicine, King Abdulaziz University, Jeddah, SAU., Alghamdi A; Community Medicine, King Abdulaziz University Faculty of Medicine, Jeddah, SAU., Abusayf MM; Ophthalmology Department, King Saud University, Riyadh, SAU., Ahad MA; Cornea and External Disease Division, King Khaled Eye Specialist Hospital, Riyadh, SAU. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2024 May 01; Vol. 16 (5), pp. e59431. Date of Electronic Publication: 2024 May 01 (Print Publication: 2024). |
| DOI: | 10.7759/cureus.59431 |
| Abstrakt: | Scleroderma is an autoimmune disease that affects connective tissue. Keratoconus (KC) is a rare ocular condition that may appear alongside scleroderma. Contact lenses are an essential visual aid for KC patients, especially in advanced cases. However, scleroderma patients may face difficulties using them due to finger-related disabilities. Corneal collagen cross-linking (CXL) is a crucial treatment used to prevent corneal thinning and visual deterioration in progressive KC. However, the potential trigger of corneal melt and delayed healing following CXL in KC patients with scleroderma is a matter of concern. We present a case of a patient with KC and scleroderma who underwent CXL without any complications. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Alghamdi et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|